• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 HPV 相关癌症的多任务学习提高五年生存率预测。

Improving five-year survival prediction via multitask learning across HPV-related cancers.

机构信息

Lawrence Livermore National Laboratory, Livermore, CA, United States of America.

Cancer Registry of Norway, Oslo, Norway.

出版信息

PLoS One. 2020 Nov 16;15(11):e0241225. doi: 10.1371/journal.pone.0241225. eCollection 2020.

DOI:10.1371/journal.pone.0241225
PMID:33196642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7668590/
Abstract

Oncology is a highly siloed field of research in which sub-disciplinary specialization has limited the amount of information shared between researchers of distinct cancer types. This can be attributed to legitimate differences in the physiology and carcinogenesis of cancers affecting distinct anatomical sites. However, underlying processes that are shared across seemingly disparate cancers probably affect prognosis. The objective of the current study is to investigate whether multitask learning improves 5-year survival cancer patient survival prediction by leveraging information across anatomically distinct HPV related cancers. Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) program database. The study cohort consisted of 29,768 primary cancer cases diagnosed in the United States between 2004 and 2015. Ten different cancer diagnoses were selected, all with a known association with HPV risk. In the analysis, the cancer diagnoses were categorized into three distinct topography groups of varying specificity. The most specific topography grouping consisted of 10 original cancer diagnoses differentiated by the first two digits of the ICD-O-3 topography code. The second topography grouping consisted of cancer diagnoses categorized into six distinct organ groups. Finally, the third topography grouping consisted of just two groups, head-neck cancers and ano-genital cancers. The tasks were to predict 5-year survival for patients within the different topography groups using 14 predictive features which were selected among descriptive variables available in the SEER database. The information from the predictive features was shared between tasks in three different ways, resulting in three distinct predictive models: 1) Information was not shared between patients assigned to different tasks (single task learning); 2) Information was shared between all patients, regardless of task (pooled model); 3) Only relevant information was shared between patients grouped to different tasks (multitask learning). Prediction performance was evaluated with Brier scores. All three models were evaluated against one another on each of the three distinct topography-defined tasks. The results showed that multitask classifiers achieved relative improvement for the majority of the scenarios studied compared to single task learning and pooled baseline methods. In this study, we have demonstrated that sharing information among anatomically distinct cancer types can lead to improved predictive survival models.

摘要

肿瘤学是一个高度专业化的研究领域,亚学科专业化限制了不同癌症类型的研究人员之间信息的共享。这可以归因于影响不同解剖部位的癌症在生理学和癌变方面的合理差异。然而,跨看似不同的癌症共享的潜在过程可能会影响预后。本研究的目的是调查是否通过利用跨解剖学上不同的 HPV 相关癌症的信息,多任务学习可以提高 5 年生存率癌症患者的生存预测。数据来自监测、流行病学和最终结果 (SEER) 计划数据库。研究队列包括 2004 年至 2015 年期间在美国诊断的 29768 例原发性癌症病例。选择了十种不同的癌症诊断,所有这些诊断都与 HPV 风险有关。在分析中,癌症诊断被分为三个不同的特定解剖部位分组,特异性逐渐增强。最特定的解剖部位分组由 10 种原始癌症诊断组成,这些诊断通过 ICD-O-3 解剖部位代码的前两位数字区分。第二个解剖部位分组由分为六个不同器官组的癌症诊断组成。最后,第三个解剖部位分组只有两组,头颈部癌症和肛门生殖器癌症。任务是使用 14 个预测特征预测不同解剖部位组的患者的 5 年生存率,这些特征是从 SEER 数据库中可用的描述性变量中选择的。任务之间通过三种不同的方式共享预测特征的信息,从而产生三个不同的预测模型:1)不同任务分配的患者之间不共享信息(单任务学习);2)无论任务如何,所有患者之间都共享信息(池化模型);3)仅在分配给不同任务的患者之间共享相关信息(多任务学习)。使用 Brier 分数评估预测性能。在每个三个不同的解剖部位定义的任务上,分别对所有三个模型进行评估。结果表明,与单任务学习和池化基线方法相比,多任务分类器在大多数研究场景中都实现了相对改善。在这项研究中,我们已经证明了在解剖学上不同的癌症类型之间共享信息可以导致改进的预测生存模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a8/7668590/98a9dea112d1/pone.0241225.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a8/7668590/98a9dea112d1/pone.0241225.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a8/7668590/98a9dea112d1/pone.0241225.g004.jpg

相似文献

1
Improving five-year survival prediction via multitask learning across HPV-related cancers.通过 HPV 相关癌症的多任务学习提高五年生存率预测。
PLoS One. 2020 Nov 16;15(11):e0241225. doi: 10.1371/journal.pone.0241225. eCollection 2020.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
A novel multitask learning algorithm for tasks with distinct chemical space: zebrafish toxicity prediction as an example.一种用于具有不同化学空间任务的新型多任务学习算法:以斑马鱼毒性预测为例。
J Cheminform. 2024 Aug 2;16(1):91. doi: 10.1186/s13321-024-00891-4.
5
Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).浆细胞骨髓瘤——按年龄、性别、种族、分期、队列入组时间和疾病持续时间对三种浆细胞骨髓瘤国际疾病分类肿瘤学形态进行的20年生存和死亡率比较:对1973 - 2014年诊断的111,041例病例的系统评价:(监测、流行病学和最终结果*统计8.3.4)
J Insur Med. 2018;47(4):203-211. doi: 10.17849/insm-47-04-1-9.1. Epub 2019 Jan 22.
6
Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.应用新型机器学习框架,利用监测、流行病学和最终结果(SEER)数据库预测男性非转移性前列腺癌特异性死亡率。
Lancet Digit Health. 2021 Mar;3(3):e158-e165. doi: 10.1016/S2589-7500(20)30314-9. Epub 2021 Feb 3.
7
Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.肛门癌幸存者中与人类乳头瘤病毒相关的第二癌症风险增加。
Cancer. 2017 Oct 15;123(20):4013-4021. doi: 10.1002/cncr.30828. Epub 2017 Jun 13.
8
Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.SORG 算法能否预测软骨肉瘤患者的 5 年生存率?一项外部验证。
Clin Orthop Relat Res. 2019 Oct;477(10):2296-2303. doi: 10.1097/CORR.0000000000000748.
9
Automatic extraction of cancer registry reportable information from free-text pathology reports using multitask convolutional neural networks.使用多任务卷积神经网络从自由文本病理报告中自动提取癌症登记报告信息。
J Am Med Inform Assoc. 2020 Jan 1;27(1):89-98. doi: 10.1093/jamia/ocz153.
10
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?骨肿瘤研究组算法对软骨肉瘤患者 5 年生存率的预测在国际验证中的表现如何?
Clin Orthop Relat Res. 2020 Oct;478(10):2300-2308. doi: 10.1097/CORR.0000000000001305.

引用本文的文献

1
Tumor HPV Status, Level of Regulatory T Cells and Macrophage Infiltration Predict up to 20-Year Non-Disease-Specific Survival in Oropharynx Squamous Cell Carcinoma Patients.肿瘤人乳头瘤病毒状态、调节性T细胞水平和巨噬细胞浸润可预测口咽鳞状细胞癌患者长达20年的非疾病特异性生存率。
Biomedicines. 2022 Oct 5;10(10):2484. doi: 10.3390/biomedicines10102484.
2
Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma.诊断时CD3、Foxp3(+)淋巴细胞和CD68巨噬细胞的肿瘤浸润水平可预测口咽鳞状细胞癌患者的5年疾病特异性生存率。
Cancers (Basel). 2022 Mar 15;14(6):1508. doi: 10.3390/cancers14061508.

本文引用的文献

1
Bayesian multitask learning regression for heterogeneous patient cohorts.用于异质患者队列的贝叶斯多任务学习回归
J Biomed Inform. 2019;100S:100059. doi: 10.1016/j.yjbinx.2019.100059. Epub 2019 Oct 18.
2
Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.在一个低流行地区,EB 病毒和人乳头瘤病毒血清抗体可定义鼻咽癌的病毒状态。
Int J Cancer. 2020 Jul 15;147(2):461-471. doi: 10.1002/ijc.33006. Epub 2020 Apr 24.
3
Prognostic Significance of HPV DNA and p16 in Anal Cancer: A Systematic Review and Meta-Analysis.
HPV DNA 和 p16 在肛门癌中的预后意义:系统评价和荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):703-710. doi: 10.1158/1055-9965.EPI-19-1259. Epub 2020 Feb 12.
4
HPV status in patients with nasopharyngeal carcinoma in the United States: A SEER database study.美国鼻咽癌患者的 HPV 状况:一项 SEER 数据库研究。
Am J Otolaryngol. 2019 Sep-Oct;40(5):705-710. doi: 10.1016/j.amjoto.2019.06.007. Epub 2019 Jun 26.
5
HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.HPV 独立型外阴鳞癌与 HPV 相关肿瘤相比,预后明显更差。
Int J Gynecol Pathol. 2020 Jul;39(4):391-399. doi: 10.1097/PGP.0000000000000620.
6
HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.头颈部非口咽鳞状细胞癌中的人乳头瘤病毒状态与生存情况
Anticancer Res. 2019 Apr;39(4):1907-1914. doi: 10.21873/anticanres.13299.
7
A guide to deep learning in healthcare.深度学习在医疗保健中的应用指南。
Nat Med. 2019 Jan;25(1):24-29. doi: 10.1038/s41591-018-0316-z. Epub 2019 Jan 7.
8
Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis.人乳头瘤病毒在外阴癌中的流行情况及其预后价值:系统评价和荟萃分析。
PLoS One. 2018 Sep 26;13(9):e0204162. doi: 10.1371/journal.pone.0204162. eCollection 2018.
9
Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.人乳头瘤病毒相关癌症的长期发病趋势以及可通过人乳头瘤病毒疫苗预防的病例:挪威一项基于登记处的研究
BMJ Open. 2018 Feb 23;8(2):e019005. doi: 10.1136/bmjopen-2017-019005.
10
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年(CONCORD-3):对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.